Evaluating the pathogenicity of novel germline RET sequence variants

• Research type

  Research Study

• Full title

  Evaluating the pathogenicity of novel germline variants in the RET gene, associated with phaeochromocytoma, C-cell hyperplasia, features of multiple endocrine neoplasia type 2.

• IRAS ID

  118008

• Contact name

  Louise Izatt

• Contact email

  louise.izatt@gstt.nhs.uk

• Sponsor organisation

  Clincal Genetics

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  13/SC/0574

• Date of REC Opinion

  4 Dec 2013

• REC opinion

  Further Information Favourable Opinion